BusinessIHMA Completes the Globalization of its Two Laboratories with the Recent College of American Pathologists (CAP) Accreditation of IHMA Europe, Enhancing Support for Clinical Trials in Anti-Infective Drug Development and Global Surveillance StudiesBy Nasdaq OMXMar 6, 2018, 10:20 PM UTC
BusinessSummit Obtains Innovative Antibiotic Discovery and Development Platform Through Acquisition of Discuva LtdBy Nasdaq OMXDec 23, 2017, 9:00 PM UTC
BusinessNTS Ventures and IHMA Announce a Collaborative Agreement to Provide an Extensive Suite of Clinical Mycology, Antifungal and Microbiology Laboratory Services to Support Anti-infective Drug Development to the Biopharmaceutical IndustryBy Nasdaq OMXDec 4, 2017, 10:24 PM UTC
BusinessSummit Highlights Microbiome Preservation During Ridinilazole Treatment in Exploratory Phase 2 Clinical Trial at ID Week 2017By Nasdaq OMXOct 9, 2017, 11:00 AM UTC
BusinessCidara Provides Corporate Update and Reports Second Quarter 2017 Financial ResultsBy Nasdaq OMXAug 9, 2017, 8:31 PM UTC
BusinessCidara Therapeutics to Host Investor Day on April 6, 2017By Nasdaq OMXMar 29, 2017, 11:33 AM UTC
BusinessCidara Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial ResultsBy Nasdaq OMXMar 15, 2017, 9:23 PM UTC
BusinessCidara Provides Corporate Update and Reports Third Quarter 2016 Financial ResultsBy Nasdaq OMXNov 10, 2016, 9:11 PM UTC
